First thought was from an investor's point of view.
From nature, a first-rate, highly respected magazine. This was back from June, 2022, a few months ago. Not sure how much farther along China is.
From the linked nature article:
China is getting closer to approving its first mRNA vaccine to protect people against COVID-19. In a small clinical trial, the Chinese vaccine candidate triggered a stronger antibody response in vaccinated adults when given as a booster shot than did a jab containing inactivated SARS-CoV-2, the vaccine platform that the country has mostly relied on so far.
The experimental jab, called ArCoV, is a strong candidate to become China’s first approved mRNA vaccine. But ....
So far, the Chinese drug regulator has approved seven COVID-19 vaccines. Most residents of China are vaccinated with one of two inactivated-virus vaccines, either CoronaVac, made by Beijing-based company Sinovac, or BBIBP-CorV, made by the state-supported company Sinopharm in Beijing. The inactivated-virus vaccines are effective at reducing the risk of hospitalization and death1, but provide less protection than do the two mRNA vaccines developed by Pfizer–BioNTech and Moderna, which have been used widely outside China.
“From data of all the COVID-19 vaccines available in the world, the mRNA technology seems to be better compared to other technologies,” says Feng Gao, a virologist at Jinan University in Guangzhou, China.
Chinese companies had planned to import the mRNA vaccine made by BioNTech and Pfizer.
As early as March 2020, a Shanghai-based drug company, Fosun Pharma, struck a deal with BioNTech to sell its vaccine on the Chinese mainland and in Hong Kong once the regulators greenlit the product.
But the approval of the highly effective vaccine is still pending on the mainland, despite data from a phase II trial in China showing that the vaccine triggers a robust immune response and is safe to use in adults.
I do not know of any new data but I'm sure there's plenty of information out there.
For investing, not trading, my "new money allocation" remains:
- Buffett, blue chip, 40%
- tech infrastructure (mostly chips), 30%
- energy (mostly oil), 20%
- mRNA, 10%
I have a 30-year horizon.
Disclaimer: this is not an investment
site. Do not make any investment, financial, job, career, travel, or
relationship decisions based on what you read here or think you may have
read here.
All my posts are done quickly:
there will be content and typographical errors. If anything on any of
my posts is important to you, go to the source. If/when I find
typographical / content errors, I will correct them.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.